Propella Therapeutics, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Vizuri Health Sciences LLC
See more in Biomedtracker
Latest on Propella Therapeutics, Inc.
In Vivo
• By Joseph Haas
Deal volume was down last year both in M&A and alliances, but valuations rose. Early in 2023, Pfizer Inc. set the tone for a year of moving on from the COVID-19 pandemic by agreeing to pay $43bn for
Scrip
• By Joseph Haas and Jung Won Shin
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Novartis To Pay Argo $185m Up Fron
Scrip
• By Ian Haydock
Astellas Pharma, Inc. is to acquire the private US company Propella Therapeutics, Inc. in a $175m deal that will bring with it an early clinical-stage asset for prostate cancer, a core area of inte